Search

everythinglearnresearchcommunity

for

Search:↓

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Prostaglandins may protect hair follicles during chemotherapy.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Further research is needed to develop effective cancer prevention strategies.

Hair loss from chemotherapy causes significant distress and affects social roles for ovarian and uterine cancer patients.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Oral minoxidil may effectively treat hair loss from chemotherapy.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Families help manage chemotherapy side effects at home by providing preferred foods, keeping hair short, assisting with routines, and ensuring hydration.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.